Angela M Liu1, Ronnie T P Poon, John M Luk. 1. Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, China.
Abstract
UNLABELLED: Hepatocellular carcinoma (HCC) is a malignant form of liver cancer that ranks the second leading cause of cancer-related deaths in China and many Asia regions. The dismal outcome reflects the need for a better understanding of the transcriptional control of oncogenic signaling pathway. Our recent findings have identified yes-associated protein (YAP) is a potent oncogenic driver and independent prognostic risk factor of HCC. The present study aims to elucidate the transcriptional regulation of YAP targeted by microRNA (miRNA). miR-375 is a putative target and was found significantly down-regulated in the tumor versus adjacent non-tumor tissues of HCC patients (n=48). As determined by luciferase reporter assay, we found ectopic expression of miR-375 could diminish the transcriptional activity of YAP. Furthermore, immunoblotting revealed miR-375 suppressed endogenous YAP protein level. Functional assays showed that miR-375 was able to inhibit proliferation and invasion of HCC cells. CONCLUSION: miR-375 is an important regulator of YAP oncogene, implicating a potential therapeutic role in HCC treatment. Copyright 2010 Elsevier Inc. All rights reserved.
UNLABELLED: Hepatocellular carcinoma (HCC) is a malignant form of liver cancer that ranks the second leading cause of cancer-related deaths in China and many Asia regions. The dismal outcome reflects the need for a better understanding of the transcriptional control of oncogenic signaling pathway. Our recent findings have identified yes-associated protein (YAP) is a potent oncogenic driver and independent prognostic risk factor of HCC. The present study aims to elucidate the transcriptional regulation of YAP targeted by microRNA (miRNA). miR-375 is a putative target and was found significantly down-regulated in the tumor versus adjacent non-tumor tissues of HCC patients (n=48). As determined by luciferase reporter assay, we found ectopic expression of miR-375 could diminish the transcriptional activity of YAP. Furthermore, immunoblotting revealed miR-375 suppressed endogenous YAP protein level. Functional assays showed that miR-375 was able to inhibit proliferation and invasion of HCC cells. CONCLUSION:miR-375 is an important regulator of YAP oncogene, implicating a potential therapeutic role in HCC treatment. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: Rom S Leidner; Lakshmeswari Ravi; Patrick Leahy; Yanwen Chen; Beth Bednarchik; Mirte Streppel; Marcia Canto; Jean S Wang; Anirban Maitra; Joseph Willis; Sanford D Markowitz; Jill Barnholtz-Sloan; Mark D Adams; Amitabh Chak; Kishore Guda Journal: Genes Chromosomes Cancer Date: 2012-02-03 Impact factor: 5.006
Authors: Lizandra Jimenez; Ved P Sharma; John Condeelis; Thomas Harris; Thomas J Ow; Michael B Prystowsky; Geoffrey Childs; Jeffrey E Segall Journal: Arch Pathol Lab Med Date: 2015-07-14 Impact factor: 5.534
Authors: John M Luk; Julja Burchard; Chunsheng Zhang; Angela M Liu; Kwong F Wong; Felix H Shek; Nikki P Lee; Sheung Tat Fan; Ronnie T Poon; Irena Ivanovska; Ulrike Philippar; Michele A Cleary; Carolyn A Buser; Peter M Shaw; Chuen-Neng Lee; Daniel G Tenen; Hongyue Dai; Mao Mao Journal: J Biol Chem Date: 2011-07-07 Impact factor: 5.157
Authors: Julja Burchard; Chunsheng Zhang; Angela M Liu; Ronnie T P Poon; Nikki P Y Lee; Kwong-Fai Wong; Pak C Sham; Brian Y Lam; Mark D Ferguson; George Tokiwa; Ryan Smith; Brendan Leeson; Rebecca Beard; John R Lamb; Lee Lim; Mao Mao; Hongyue Dai; John M Luk Journal: Mol Syst Biol Date: 2010-08-24 Impact factor: 11.429